Dr. Robert M. Jasmer, MD

Dr. Jasmer practices at Mid Peninsula Endoscopy Center in Burlingame, California.

Dr. Jasmer's NPI, 1891746574, was assigned on May 15, 2006. Dr. Jasmer graduated from WashU Medicine in 1990. Dr. Jasmer holds California license G72423.

Dr. Jasmer's primary practice is Mid Peninsula Endoscopy Center, at 1720 El Camino Real, Suite 100, Burlingame, CA 94010. The practice phone is (650) 373-1970.

Dr. Jasmer's primary practice is Mid Peninsula Endoscopy Center in Burlingame, California. Dr. Jasmer is also affiliated with Mills-Peninsula Medical Center. The medical group on file is Pulmonary Associates. Dmand AI also links Dr. Jasmer to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jasmer practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Jasmer's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Jasmer is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Jasmer's licenses on file in 2 states: California and Florida.

Dmand AI lists acute sinusitis, asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, hypersomnia and pleural effusion among the conditions Dr. Jasmer treats.

CMS data shows 1,578 Medicare services from Dr. Jasmer across 25 procedure codes in 2024, for 511 Medicare patients. Medicare paid $164,593 for them.

CMS counts 511 Medicare patients who saw Dr. Jasmer in 2024. The largest group is 75 to 84, with 233 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jasmer's median patient age at 76, with 52% women.

In 2024, Dr. Jasmer wrote 2,300 Medicare Part D claims for 382 patients. CMS names the drug for 2,115 of them, across 44 drugs with 11 or more claims each, at $1,245,979 in total drug cost. In 2023, CMS named 2,162 claims across 43 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Jasmer for performance year 2024, reported individually. Dr. Jasmer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jasmer as offering telehealth.

Dmand AI links 28 papers to Dr. Jasmer, published from 2003 to 2004. 2004 was the busiest year, with 2. The most frequent topics are Tuberculosis, Pulmonary, Antitubercular Agents and San Francisco. Dr. Jasmer has published most often in Am J Respir Crit Care Med. Dr. Jasmer's most frequent co-authors are Philip Christy Hopewell, MD, Charles L. Daley, MD and Laurence Huang, MD.

CMS Open Payments shows 1,172 general payments to Dr. Jasmer from 58 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 41% of the total. Insmed, Inc. paid the most, $42,544.

Dmand AI lists 2 awards for Dr. Jasmer, most recently CMS Stage 1 EHR in 2013.

Dr. Jasmer graduated from WashU Medicine in 1990.

Dr. Jasmer is in network with 12 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.